NRx Pharmaceuticals takes second shot a getting emergency use approval for Covid-19 treatment
January 05, 2022 at 10:14 AM EST
The Food and Drug Administration rejected an earlier request made by the company last year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|